0.4118
                                            
            Can-Fite Biopharma Ltd ADR stock is traded at $0.4118, with a volume of 174.95K.
            It is down -2.56% in the last 24 hours and down -33.58% over the past month.
            Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological, and liver diseases, as well as sexual dysfunction. The company's lead drug candidate is CF101 (Piclidenoson), which is in Phase III clinical trials for the treatment of rheumatoid arthritis and psoriasis. It also develops CF102 (Namodenoson) that is in Phase II clinical trials for the treatment of liver cancer and non-alcoholic fatty liver diseases, as well as for hepatocellular carcinoma and hepatitis C virus diseases; and CF602, which is in pre-clinical trial for the treatment of sexual dysfunction. Can-Fite BioPharma Ltd. was founded in 1994 and is headquartered in Petah-Tikva, Israel.
        
        See More
    Previous Close:
              $0.4226
            Open:
              $0.41
            24h Volume:
                174.95K
            Relative Volume:
              0.91
            Market Cap:
                $634.75K
            Revenue:
              $743.00K
            Net Income/Loss:
              $-7.63M
            P/E Ratio:
              -0.1373
            EPS:
                -3
            Net Cash Flow:
                -
            1W Performance:
              -13.29%
            1M Performance:
              -33.58%
            6M Performance:
                -63.40%
            1Y Performance:
              -80.94%
            Can-Fite Biopharma Ltd ADR Stock (CANF) Company Profile
Name
                  
                      Can-Fite Biopharma Ltd ADR
                    
                Sector
                  Industry
                  Phone
                  
                      972 3 924 1114
                    
                Address
                  
                      10 Bareket Street, Kiryat Matalon PO Box 7537, Petah-Tikva
                    
                Compare CANF with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                CANF
                            
                             
                        Can-Fite Biopharma Ltd ADR 
                           | 
                    0.4118 | 7.22M | 743.00K | -7.63M | 0 | -3.00 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Can-Fite Biopharma Ltd ADR Stock (CANF) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change | 
|---|---|---|---|
| Aug-11-17 | Initiated | Maxim Group | Buy | 
| Oct-19-16 | Resumed | ROTH Capital | Buy | 
| Aug-29-16 | Resumed | Rodman & Renshaw | Buy | 
| Nov-30-15 | Reiterated | H.C. Wainwright | Buy | 
| Mar-31-15 | Reiterated | H.C. Wainwright | Buy | 
| Mar-30-15 | Downgrade | ROTH Capital | Buy → Neutral | 
| Dec-29-14 | Reiterated | ROTH Capital | Buy | 
| Nov-18-14 | Initiated | H.C. Wainwright | Buy | 
                    View All
                    
                  
                Can-Fite Biopharma Ltd ADR Stock (CANF) Latest News
Can Can Fite Biopharma Ltd Sponsored ADR stock deliver double digit returnsMarket Growth Summary & Short-Term Trading Opportunity Alerts - newser.com
Will Can Fite Biopharma Ltd Sponsored ADR stock see insider accumulation2025 Market WrapUp & Stock Timing and Entry Methods - newser.com
How big funds are accumulating Can Fite Biopharma Ltd Sponsored ADR stockTrade Ideas & Weekly Top Gainers Trade List - newser.com
Why retail traders accumulate Can Fite Biopharma Ltd Sponsored ADR stockJuly 2025 Sector Moves & Fast Exit Strategy with Risk Control - newser.com
Will Can Fite Biopharma Ltd Sponsored ADR stock benefit from mergersMarket Sentiment Report & Real-Time Volume Spike Alerts - fcp.pa.gov.br
Why Can Fite Biopharma Ltd Sponsored ADR stock could rally stronglyJuly 2025 Technicals & Free Community Supported Trade Ideas - fcp.pa.gov.br
Why Can Fite Biopharma Ltd Sponsored ADR stock is a strong analyst pickQuarterly Profit Report & Free Technical Confirmation Trade Alerts - newser.com
Why Can Fite Biopharma Ltd Sponsored ADR stock is a strong buy callTake Profit & Verified Momentum Stock Ideas - newser.com
Will Can Fite Biopharma Ltd Sponsored ADR stock beat growth indexesJuly 2025 Big Picture & AI Enhanced Trading Alerts - newser.com
Why Can Fite Biopharma Ltd Sponsored ADR stock could outperform next yearGlobal Markets & Weekly Return Optimization Alerts - newser.com
Why pension funds invest in Can Fite Biopharma Ltd Sponsored ADR stockJuly 2025 Selloffs & Reliable Trade Execution Plans - newser.com
Why Can Fite Biopharma Ltd Sponsored ADR stock fits value portfolios2025 Bull vs Bear & Smart Allocation Stock Reports - newser.com
Is Can Fite Biopharma Ltd Sponsored ADR stock expanding market penetration2025 Historical Comparison & AI Powered Buy and Sell Recommendations - newser.com
Is Can Fite Biopharma Ltd Sponsored ADR stock a contrarian opportunityEarnings Miss & Real-Time Volume Triggers - newser.com
Can-Fite Biopharma Ltd ADR Stock (CANF) Financials Data
Revenue
Net Income
Cash Flow
EPS
        Open in Yahoo
        |
        Open in Google
            |
            Open in Finviz
        |
        Open in MarketWatch
            |
            Open in EDGAR    
        |
        Open in Reuters
    
    
                Cap:
                 
                  | 
                Volume (24h):